Stephen Baxter
Stock Analyst at Wells Fargo
(3.13)
# 1,119
Out of 4,778 analysts
167
Total ratings
42.31%
Success rate
0.95%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Equal-Weight | $641 → $691 | $664.00 | +4.07% | 5 | Mar 14, 2025 | |
| COR Cencora | Maintains: Equal-Weight | $251 → $274 | $268.47 | +2.06% | 2 | Mar 14, 2025 | |
| OSCR Oscar Health | Downgrades: Equal-Weight | $20 → $16 | $14.19 | +12.76% | 10 | Mar 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $230 → $225 | $185.92 | +21.02% | 13 | Mar 10, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2.5 → $2 | $2.82 | -29.08% | 8 | Mar 10, 2025 | |
| MOH Molina Healthcare | Upgrades: Overweight | $295 → $372 | $310.49 | +19.81% | 17 | Mar 5, 2025 | |
| CNC Centene | Maintains: Overweight | $76 → $72 | $58.94 | +22.16% | 21 | Feb 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $68 → $73 | $66.51 | +9.77% | 13 | Feb 13, 2025 | |
| CI The Cigna Group | Maintains: Equal-Weight | $370 → $341 | $316.54 | +7.73% | 6 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Equal-Weight | $135 → $136 | $132.75 | +2.45% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $694 → $660 | $513.45 | +28.54% | 10 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $483 → $478 | $423.64 | +12.83% | 9 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $21 | $18.64 | +12.66% | 3 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $205 → $150 | $130.82 | +14.66% | 12 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $400 → $320 | $336.38 | -4.87% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $273.99 | +5.84% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $8.65 | +73.51% | 3 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $8 | $4.48 | +78.77% | 6 | Feb 26, 2024 |
McKesson
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $641 → $691
Current: $664.00
Upside: +4.07%
Cencora
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $251 → $274
Current: $268.47
Upside: +2.06%
Oscar Health
Mar 13, 2025
Downgrades: Equal-Weight
Price Target: $20 → $16
Current: $14.19
Upside: +12.76%
Universal Health Services
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $185.92
Upside: +21.02%
Community Health Systems
Mar 10, 2025
Maintains: Underweight
Price Target: $2.5 → $2
Current: $2.82
Upside: -29.08%
Molina Healthcare
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $310.49
Upside: +19.81%
Centene
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $58.94
Upside: +22.16%
CVS Health
Feb 13, 2025
Maintains: Overweight
Price Target: $68 → $73
Current: $66.51
Upside: +9.77%
The Cigna Group
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $316.54
Upside: +7.73%
Cardinal Health
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $135 → $136
Current: $132.75
Upside: +2.45%
Jan 28, 2025
Maintains: Overweight
Price Target: $694 → $660
Current: $513.45
Upside: +28.54%
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $423.64
Upside: +12.83%
Nov 27, 2024
Maintains: Overweight
Price Target: $17 → $21
Current: $18.64
Upside: +12.66%
Nov 25, 2024
Downgrades: Equal-Weight
Price Target: $205 → $150
Current: $130.82
Upside: +14.66%
Nov 25, 2024
Downgrades: Underweight
Price Target: $400 → $320
Current: $336.38
Upside: -4.87%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $273.99
Upside: +5.84%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $8.65
Upside: +73.51%
Feb 26, 2024
Maintains: Overweight
Price Target: $16 → $8
Current: $4.48
Upside: +78.77%